K

Kankana Bardhan

Seres Therapeutics (United States)

ORCID: 0000-0002-6995-1205

66 papers and 2.9k citations.

PubIndex Score12Top 88% · mid-careerHow it's scored

66Publications

2.9kTotal Citations

First publication: 2011First senior author: 2015

Top publicationsby citations

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

Kankana Bardhan, Vassiliki A. Boussiotis|Frontiers in Immunology|2016

Cited by 596

Indexing the rest of 66 publications…